Tonix Pharmaceuticals Holding Corp. Inventory Write-down
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-10
- Tonix Pharmaceuticals Holding Corp. inventory write-down for the quarter ending 2025-12-31 was -$649.00K.
- Tonix Pharmaceuticals Holding Corp. inventory write-down for the quarter ending 2025-09-30 was -$962.00K, a 443.57% decline year-over-year.
- Tonix Pharmaceuticals Holding Corp. inventory write-down for the quarter ending 2024-12-31 was -$528.00K.
- Tonix Pharmaceuticals Holding Corp. inventory write-down for the quarter ending 2024-09-30 was $280.00K.
- Tonix Pharmaceuticals Holding Corp. inventory write-down for fiscal 2025 was $669.00K, a 55.10% decline from fiscal 2024.
- Tonix Pharmaceuticals Holding Corp. inventory write-down for fiscal 2024 was $1.49M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.61M derived: sum of 2 quarters · filed 2026-03-12 | $669.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | -$962.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.32M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $2.28M 10-Q · filed 2026-08-10 | |||
| 2024-12-31 | -$528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$248.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.45M derived: sum of 3 quarters · filed 2026-03-12 | $1.49M 10-K · filed 2026-03-12 |
| 2024-09-30 | $280.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.98M derived: sum of 2 quarters · filed 2025-11-10 | $2.02M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $1.70M 10-Q · filed 2024-08-16 | $1.74M 10-Q · filed 2025-08-11 |